Multi-omics-based identification of METTL11B as a novel biomarker in esophageal squamous cell carcinoma

Acta Pharmaceutica Sinica B 2026 Open access

Read full text
Authors: Wenke Jin, Hongyao Li, Yanmei Chen, Wei Wang, Rui Liu, Ning Li, Yong Yuan
DOI: 10.1016/j.apsb.2026.01.025
Cited by: 1
References: 12

Abstract

To the Editor:Esophageal cancer, the seventh most lethal cancer in the world, is divided into two pathologically distinct subtypes: esophageal squamous cell carcinoma (ESCC; accounts for over 90%) and esophageal adenocarcinoma, which differ significantly in risk and geographic factors 1,2 .The major geographic prevalence of ESCC is in East Asia, with China accounting for more than half of all cases worldwide 3 .Despite advances in diagnostic and therapeutic modalities, the five-year overall survival for ESCC patients remains dismal (

Fields of Study & Subjects

Esophageal Cancer Research and Treatment Cancer Cells and Metastasis Lung Cancer Treatments and Mutations

Publication details

Journal / source
Acta Pharmaceutica Sinica B
Publisher
Elsevier BV
Volume
16
Issue
3
Pages
1773–1778
Publication date
23 January 2026
Language
EN